Home › Cancro alla prostata › Utah › Salt Lake City
Studi clinici su Cancro alla prostata a Salt Lake City, UT
15 studi su Cancro alla prostata cercano partecipanti presso sedi a Salt Lake City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
In reclutamentoFase 2
- Huntsman Cancer Institute and Hospital, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
In reclutamentoFase 3
- LDS Hospital, Salt Lake City
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
In reclutamentoFase 3
- Huntsman Cancer Institute, Salt Lake City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
In reclutamentoFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- LDS Hospital, Salt Lake City
- e altri 1
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
In reclutamentoFase 3
- Research Site, Salt Lake City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
In reclutamentoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
In reclutamentoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
In reclutamentoFase 3
- Huntsman Cancer Institute, Salt Lake City
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
In reclutamento
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Salt Lake City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
In reclutamento
- University of Utah Huntsman Cancer Institute, Salt Lake City
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Salt Lake City
- Cancro del polmone non a piccole cellule31 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno27 studi
- Cancro colorettale22 studi
- Cancro ai polmoni21 studi
- Melanoma21 studi
- Mieloma multiplo21 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Obesità18 studi
- Leucemia mieloide acuta17 studi
- Insufficienza cardiaca17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.